knowledge -WSS

knowledge

author：Wikipedia 2025-10-02 23:30:38 - browse：356

President of Bayer U.S. Sebastian Guth speaks with STAT reporters at STAT's Boston headquarters, March 13, 2024 — Bayer's U.S. president, Sebastian Guth, emphasized at an interview at the STAT offices in Boston that the pharma company is no longer just focused on small molecules. Alissa Ambrose/STAT

German pharmaceutical company Bayer is expanding its U.S. pharma business significantly, despite corporate turmoil and pricing pressures that have led many in the drug industry to bemoan the potential end of the American biotech innovation boom.

Bayer’s C-suite has been on a soul-searching mission for the last year, spurred by new leadership and the realization that the company is, as new CEO Bill Anderson said earlier this month, “badly broken.”

The biggest fissure is the debt and litigation costs stemming from Bayers’s 2018 acquisition of agriculture firm Monsanto, but the aspirin-maker’s pharmaceutical portfolio is also facing strain. Some of Bayer’s top products, including the anticoagulant drug Xarelto and the eye medication Eylea, are under patent pressure. Xarelto is also one of the first drugs to be subject to Medicare price negotiations under the Inflation Reduction Act, though Johnson & Johnson owns U.S. rights to the drug.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： HHS secretary Becerra pressed on Change HealthCare cyberattack

leisure time

WSS

Influencer to be charged after chaos erupts in New York City's Union Square

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

Verily hires former Apple Health leader as chief scientific officer

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

How many hemophilia patients actually want gene therapy?

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

hotspot

knowledge

Wikipedia

Novavax promises a turnaround & Lilly roils the obesity market

White House drug shortage group privately met with industry

ChatGPT in medicine: STAT answers readers' burning questions

Nearly two

Virginia high school admissions case could be legal follow

John Green on his newest strategy for fighting tuberculosis

ChatGPT in medicine: STAT answers readers' burning questions

'Ancient DNA,' 23andMe reveal African American ancestries

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Why scientists need input from humanists on sensitive research

leisure time

Verily hires former Apple Health leader as chief scientific officer

White House drug shortage group privately met with industry

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

Dramatically reducing cancer deaths requires the PASTEUR Act

For BCIs, commercial hurdles may be bigger than scientific ones

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

focus

leisure time

knowledge

explore